Skip to content

Diagnostic Biochips Plays a Pivotal Role in Emerging Neuro Technologies

As populations age across the globe, the resulting issues span from healthcare to economics, driving extensive research into age-related conditions like neurodegeneration. This has significantly advanced our understanding and treatment of disorders such as Alzheimer's and dementia. However, a surge in mental health disorders, particularly in Western countries, has also garnered attention. Conditions like major depressive disorder (MDD) and substance use disorder (SUD) are now receiving the scientific focus they deserve, thanks to an increased awareness and the development of new technologies.

In human applications, Diagnostic Biochips facilitate a safe and effective use of electrophysiology techniques during neurosurgical procedures. For instance, in epilepsy and Parkinson's disease treatments, DBC's Deep Array helps  record neural activity, guiding the placement of therapeutic devices like deep brain stimulators (DBS). This integration ensures precise targeting and monitoring, enhancing the efficacy of these interventions.

Read the full article -- Recording the Brain in Vivo: Emerging Technologies for the Exploration of Mental Health Conditions